The DUTCH (Dried Urine Test for Comprehensive Hormones) measures over 35 hormones and metabolites from dried urine samples, offering insights into oestrogen metabolism, cortisol patterns, and adrenal health. It provides more detail than a standard blood test but is not a diagnostic tool; it works best alongside a comprehensive clinical assessment from a menopause-focused healthcare provider.
If you've been dealing with persistent symptoms of menopause — fatigue, mood swings, disrupted sleep, or unexplained weight changes — but your standard blood tests keep coming back 'normal', you're not alone. Many women find themselves in this frustrating grey zone. The DUTCH hormone test has emerged as a tool practitioners are increasingly using to dig deeper, measuring not just hormone levels, but how your body processes and eliminates them. Below, we explore what the DUTCH test reveals, how it compares to standard testing, who it may suit, and how it fits into a holistic menopause care approach.
DUTCH stands for Dried Urine Test for Comprehensive Hormones. It's an at-home testing method developed by Precision Analytical, in which you collect four to five dried urine samples on filter paper at various points throughout a 24-hour period. These samples are then sent to a laboratory for analysis.
The test uses liquid chromatography-mass spectrometry (LC-MS/MS) to measure a wide range of hormones and their metabolites. Research has demonstrated that dried urine spot samples show excellent agreement with traditional 24-hour liquid urine collections, making the four-sample approach a more practical alternative [1].
You collect urine samples at set times: typically dinnertime the evening before, then first thing in the morning, mid-morning, and afternoon the following day. Dried samples are stable for weeks, making them easy to ship to the laboratory. Unlike a single blood draw, the multi-sample approach captures how your hormones fluctuate across the day — particularly relevant for cortisol.
The DUTCH test is not covered by Medicare or most private health insurance in Australia, and costs can range broadly depending on the panel chosen — making it an out-of-pocket consideration for most women.
The DUTCH Complete panel analyses over 35 hormones and biomarkers across four main categories.
The test measures oestrogen in its three main forms — oestradiol, oestrone, and oestriol — along with progesterone metabolites and androgens including testosterone and DHEA-S. Critically, it also measures the metabolites these hormones break down into, revealing your body's oestrogen detoxification pathways.
This is where the DUTCH test differs most from a blood panel. There are three primary oestrogen metabolite pathways:
Understanding which pathways are most active may offer insights relevant to long-term health risk assessment, though careful interpretation by a knowledgeable practitioner is essential.
The DUTCH test provides a comprehensive view of cortisol across the day, measuring both free cortisol (the active form) and metabolised cortisol (which reflects total adrenal output). This is a meaningful distinction: saliva testing captures only the free fraction, which represents roughly 1% of total cortisol production. The DUTCH test captures a more complete picture of overall adrenal function.
For women in perimenopause or menopause experiencing anxiety, sleep disruption, fatigue, or heart palpitations, the cortisol pattern can add meaningful context to what's driving their symptoms.
Depending on the panel, the DUTCH test may also include melatonin, an oxidative stress marker, and organic acid markers that can point toward nutritional deficiencies or gut health considerations.
Standard blood tests measuring FSH, LH, and oestradiol remain the first-line investigation for menopause and perimenopause. They are Medicare-covered via GP referral and provide validated data for diagnosis and hormone therapy monitoring.
Important note: The 2022 North American Menopause Society (NAMS) position statement notes that salivary and urine hormone testing to determine dosing are unreliable and not recommended for routine use [2].
The DUTCH test is not a replacement for standard blood testing. Its potential value lies in what it adds — the metabolite picture — which blood tests cannot capture. For women with complex or unexplained symptoms despite normal blood work, metabolite data may offer additional context. That said, results require specialist knowledge to interpret; reference ranges are laboratory-specific and can be misread without experienced clinical oversight.
The DUTCH test is most useful in specific circumstances, not as a universal screening tool.
Tip: The DUTCH test cannot diagnose adrenal insufficiency, PCOS, thyroid disorders, or other endocrine conditions. These require standard medical investigations. Use it as a complementary tool within a broader assessment.
Being well-informed about what the DUTCH test cannot do is just as important as understanding what it can.
The primary validation studies for the DUTCH test, including a 2021 BMC Chemistry publication on dried urine hormone measurement reliability [1], were conducted by researchers associated with Precision Analytical — the company behind the test. Independent large-scale clinical trials are lacking, and major medical bodies have not incorporated urine metabolite testing into standard menopause guidelines. The data can be useful, but requires appropriately cautious interpretation.
The DUTCH test provides hormonal data — it does not diagnose conditions. A high 4-OH metabolite ratio, for example, does not mean you have cancer. These patterns are data points, not definitive answers, and must always be contextualised within your full clinical picture.
Medications, supplements, and lifestyle factors can alter urine hormone levels. Women using hormone therapy, oral contraceptives, or certain supplements should discuss this with their practitioner before testing.
Have questions about whether DUTCH testing might fit your circumstances? Our naturopaths can help you think through whether complementary testing adds useful context to your care. Book a bulk-billed consultation — no referral needed.
The DUTCH test is not a standard part of care at the Australian Menopause Centre. Our doctors do not use it to guide hormone therapy decisions. If you have specific questions about this type of testing as a complementary tool, our naturopaths are the right starting point.
The DUTCH test is a tool, not a treatment plan. Its real value depends entirely on who interprets it and how it informs next steps.
At the Australian Menopause Centre, the approach to hormonal health is integrative: evidence-based medical treatment — including body-identical hormone therapy where clinically appropriate — combined with holistic support from naturopaths and nutritionists. The menopause treatment program considers your full hormonal picture, symptoms, lifestyle, and health history, not just a single test result.
Body-identical hormone therapy uses hormones with the same molecular structure as those your body produces. Commercially available products listed in the ARTG (e.g. Prometrium; ARTG 232818/232823) are the preferred first-line option for quality and consistency. Where metabolite data adds value is in informing the holistic discussion — supporting oestrogen detoxification pathways through nutrition or lifestyle changes alongside medical treatment.
For women managing weight gain alongside hormonal changes, the DUTCH test's cortisol data may also feed into a broader weight loss program addressing the hormonal drivers of metabolic changes. The most important step remains having an experienced clinician or multidisciplinary team who can integrate all of your information into an individualised plan.
This information is for educational purposes only and is not medical advice. Consult your healthcare provider for personalised recommendations. Treatment decisions should be individualised based on your medical history and circumstances.
Yes, through registered practitioners. It is not available over the counter, and results should always be interpreted by a qualified healthcare provider.
No. Standard blood tests remain the recommended first step. The DUTCH test provides complementary information — specifically around hormone metabolism and cortisol patterns — that blood tests cannot measure. The 2022 NAMS position statement advises that urine hormone testing is not recommended for routine MHT dosing [2].
No. It is typically an out-of-pocket expense, with costs varying depending on the panel selected.
Validation research has shown that four dried urine spot samples provide excellent agreement with 24-hour liquid urine collections [1]. However, most validation studies have been conducted by researchers associated with the manufacturer, and independent large-scale clinical trials are not yet available.
Not definitively. Diagnosis of perimenopause or menopause is based on symptoms, menstrual history, and standard blood tests. The DUTCH test provides useful hormone pattern data but is not a diagnostic tool for these stages.
Speak with a menopause-focused healthcare provider who can assess your full clinical picture. Symptoms always matter, regardless of what a test shows, and a specialist can discuss whether additional investigations may help.
The DUTCH hormone test offers a more detailed picture of your hormonal landscape than a standard blood draw — particularly for oestrogen metabolism and cortisol patterns. For some women with complex or persistent symptoms, it can provide valuable additional data. However, it is not a diagnostic tool, it is not Medicare-covered, and its validation evidence has important limitations.
The test works best as part of a broader, personalised assessment that considers your full health history, symptoms, lifestyle, and treatment goals. If you have questions about whether DUTCH testing adds value to your care, our naturopaths are the right starting point.